Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monke...

Por Hirsch, V, Riedel, N, Kornfeld, H, Kanki, P J, Essex, M, Mullins, J I
Publicado em 1986

Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.

Por Hoxie, J A, Haggarty, B S, Bonser, S E, Rackowski, J L, Shan, H, Kanki, P J
Publicado em 1988

Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first line antiretroviral therapy in Nigeria

Por Hawkins, C., Chaplin, B., Idoko, J., Ekong, E., Adewole, I., Gashau, W., Murphy, R.L., Kanki, P.
Publicado em 2009

Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Por Cao, H, Kanki, P, Sankalé, J L, Dieng-Sarr, A, Mazzara, G P, Kalams, S A, Korber, B, Mboup, S, Walker, B D
Publicado em 1997

Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys.

Por Chen, Y M, Jang, Y J, Kanki, P J, Yu, Q C, Wang, J J, Montali, R J, Samuel, K P, Papas, T S
Publicado em 1994

Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria

Por Falade, C O, Adesina-Adewole, B, Dada-Adegbola, H O, Ajayi, I O, Akinyemi, J O, Ademowo, O G, Adewole, I F, Kanki, P
Publicado em 2013

Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy

Por Chaplin, B., Eisen, G., Idoko, J., Onwujekwe, D., Idigbe, E., Adewole, I., Gashau, W., Meloni, S., Sarr, A.D., Sankalé, J.L., Ekong, E., Murphy, R.L., Kanki, P.
Publicado em 2011